bindarit
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2007 (NCT01109212)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
CC(C)(OCc1nn(Cc2ccccc2)c2ccccc12)C(=O)O- Mol. weight
- 324.38 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2107549 ↗
Also known as
- 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropionic acid
- 2-((1-benzyl-3-indazolyl)methoxy)-2-methylpropionic acid
- 2-((-1-benzyl-indazol-3-yl)methoxy)-2-methylpropionic acid
- af-2838
- af-2838
- bindarit
- bindarit
- bindarit
- bindarit
- bindarit
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01269242 | Phase 2 | Jan 1, 2009 | Angelini, Vita-Salute University of Milano. Italy |
| NCT01109212 | Phase 2 | Mar 1, 2007 | Angelini, Mario Negri Institute |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Angelini | For profit | 2 | 2 | 1 | 2007 |
| Mario Negri Institute | Academic/Hospital | 1 | 0 | 1 | 2007 |
| Vita-Salute University of Milano. Italy | Academic/Hospital | 1 | 0 | 1 | 2009 |
3 organizations
Page 1 / 1